The meningioma controversy: postoperative radiation therapy
- PMID: 3403313
- DOI: 10.1016/s0360-3016(98)90008-6
The meningioma controversy: postoperative radiation therapy
Abstract
Total surgical excision is the main goal of therapy for intracranial meningiomas. The controversy today involves the efficacy of postoperative radiation therapy. To evaluate this question, 132 patients with benign intracranial meningiomas, treated between October 1964 and April 1985, were evaluated. All patients had a minimum 2-year follow-up. The actuarial local control rates at 10 years for the three treatment groups were as follows: subtotal excision alone, 18%; subtotal excision plus postoperative radiation therapy, 82%; and total excision alone, 77%. The actuarial determinate survival rates at 10 years were 49%, 81%, and 93%, respectively. Postoperative radiation therapy was also effective for patients treated at the time of the first recurrence, with an actuarial local control rate at 10 years after salvage treatment of 30% for patients treated with surgery alone and 89% for patients receiving postoperative radiation therapy at the time of salvage. This analysis suggests that radiation therapy has a significant role in the treatment of subtotally excised and recurrent intracranial meningiomas.
Similar articles
-
Role of radiation therapy in treating intracranial meningiomas.Neurosurg Focus. 2007;23(4):E4. doi: 10.3171/FOC-07/10/E4. Neurosurg Focus. 2007. PMID: 17961041 Review.
-
Radiotherapy for atypical or malignant intracranial meningioma.Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):817-22. doi: 10.1016/0360-3016(95)02166-3. Int J Radiat Oncol Biol Phys. 1996. PMID: 8598358 Review.
-
Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.J Neurosurg. 1994 Feb;80(2):195-201. doi: 10.3171/jns.1994.80.2.0195. J Neurosurg. 1994. PMID: 8283256 Review.
-
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3. Strahlenther Onkol. 2006. PMID: 17072521
-
Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.Technol Cancer Res Treat. 2005 Dec;4(6):675-82. doi: 10.1177/153303460500400612. Technol Cancer Res Treat. 2005. PMID: 16292888
Cited by
-
Expression of endothelin 1 and its angiogenic role in meningiomas.Virchows Arch. 2006 Nov;449(5):546-53. doi: 10.1007/s00428-006-0273-7. Epub 2006 Sep 30. Virchows Arch. 2006. PMID: 17013629
-
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.Radiat Oncol. 2009 Nov 18;4:56. doi: 10.1186/1748-717X-4-56. Radiat Oncol. 2009. PMID: 19922642 Free PMC article.
-
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).Neuro Oncol. 2009 Dec;11(6):853-60. doi: 10.1215/15228517-2009-010. Neuro Oncol. 2009. PMID: 19293394 Free PMC article. Clinical Trial.
-
Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas. Efficacy and safety after a follow-up of over 12 years.Strahlenther Onkol. 2015 Dec;191(12):921-7. doi: 10.1007/s00066-015-0880-9. Epub 2015 Aug 8. Strahlenther Onkol. 2015. PMID: 26253788
-
Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.J Neurooncol. 2005 Sep;74(2):157-65. doi: 10.1007/s11060-004-2337-3. J Neurooncol. 2005. PMID: 16193387 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous